ISPOR Student Presentations 18th Annual European Congress PODIUM SESSION I: MONDAY, 9 NOVEMBER 2015, 14:15 - 15:15 PRICING STUDIES

PR1

DETERMINANTS OF ORPHAN DRUG PRICES IN FRANCE: REGRESSION ANALYSIS

Daria Korchagina

University of Paris-Sud

PODIUM SESSION II: MONDAY, 9 NOVEMBER 2015, 15:45 - 16:45 EQUITY & ACCESS STUDIES

EA4

ORPHAN DESIGNATIONS AND APPROVALS IN THE EU, USA AND JAPAN

Daria Korchagina

University of Paris-Sud

PODIUM SESSION II: MONDAY, 9 NOVEMBER 2015, 15:45 - 16:45 HEALTH TECHNOLOGY ASSESSMENT STUDIES

HT4

UNDERSTANDING KEY DRIVERS OF SUCCESFUL HTA SUBMISSION - DEVELOPING A MODEL

Niels Bossers

Quintiles Advisory Services

PODIUM SESSION II: MONDAY, 9 NOVEMBER 2015, 15:45 - 16:45 RESEARCH ON METHODS STUDIES - II

RM8

COMPARISON OF TIMED AUTOMATA WITH DISCRETE EVENT SIMULATION FOR MODELING PERSONALIZED TREATMENT DECISIONS: THE CASE OF METASTATIC CASTRATION RESISTANT PROSTATE CANCER

Koen Degeling

University of Twente

POSTER SESSION I: MONDAY, 9 NOVEMBER 2015, 8:45 - 14:15 CARDIOVASCULAR DISORDERS

PCV10

PCV11 PCV113

PCV114

PCV115

PCV127

TRENDS AND CORRELATES OF PULMONARY EMBOLISM IN HOSPITALIZED SPANISH PATIENTS COMPARATIVE EFFECTIVENESS OF TRIPLE ANTIHYPERTENSIVE COMBINATION THERAPY FOR PATIENTS WITH RESISTANT HYPERTENSION IN TAIWAN DABIGATRAN FOR THE TREATMENT AND SECONDARY PREVENTION OF VENOUS THROMBOEMBOLISM A POLYPILL INTERVENTION TO IMPROVE ADHERENCE FOR SECONDARY CARDIOVASCULAR DISEASE PREVENTION IN SPAIN: A COST-EFFECTIVENESS STUDY DEVELOPMENT OF A CONCEPTUAL MODEL FOR EARLY HEALTH TECHNOLOGY ASSESSMENT OF TISSUEENGINEERED HEART VALVES ECONOMIC EVALUATION OF A PHARMACOGENOMIC TEST FOR STATIN-INDUCED MYOPATHY IN CARDIOVASCULAR HIGH-RISK PATIENTS INITIATING A STATIN

Olulade Adeola Ayodele

Decision Resources Group

Chia-Ying Lin Jelena Stevanovic

Taipei Medical University

Natalia Arrabal

Ferrer internacional

Simone A. Huygens

Erasmus Medical Centre

University of Groningen

Dominic Mitchell University of Montreal

PCV137

PCV142

PCV146

PCV16 PCV160

PCV163

PCV165

PCV17 PCV175

PCV54

PCV55 PCV63

PCV64 PCV79

PCV94 PCV97

STUDY OF KNOWLEDGE, ATTITUDE AND PRACTICE OF GENERAL POPULATION OF GUNTUR TOWARDS SILENT KILLER DISEASES : HYPERTENSION AND DIABETES EFFECT OF INTERVENTION BY COMMUNITY PHARMACISTS ON AWARENESS OF CONTINUING TREATMENT AMONG PATIENTS WITH HYPERTENSION A DISCRETE CHOICE EXPERIMENT (DCE) TO ELICIT PREFERENCES FOR ATTRIBUTES OF A BEDSIDE PHARMACOGENETIC TEST – PRELIMINARY RESULTS COMPARATIVE EFFECTIVENESS OF TICAGRELOR VS. PRASUGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME THE ATLANTIC DIVIDE IN CORONARY HEART DISEASE: HEALTH TECHNOLOGIES USE IN THE US AND PORTUGAL ANGIOTENSIN CONVERTING ENZYME INHIBITORS PRESCRIBING PATTERN FOR DIFFERENT INDICATIONS: A POPULATION BASED STUDY PRESCRIPTION PATTERN OF ANTIHYPERTENSIVE AGENTS IN A TERTIARY CARE TEACHING HOSPITAL IN CENTRAL NEPAL CAN DATA SIMULATION HELP EVALUATE HTA OUTCOMES OVER TIME AND FACILITATE EARLY DECISION-MAKING? A CASE STUDY OF TICAGRELOR IN ACUTE CORONARY SYNDROME IN THE UK NETWORK META ANALYSIS - CASE STUDY ON PULMONARY ARTERIAL HYPERTENSION (PAH) A COMPARISON OF CLASSIFICATION AND REGRESSION TREES AND LOGISTIC REGRESSION FOR PREDICTING DEATH OF OLDER LONG-TERM CARE USERS IN JAPAN PREDICTION MODEL FOR FUNCTIONAL STATUS AT DISCHARGE FOLLOWING RHABILITATION AFTER INTRACEREBRAL HEMORRHAGE AN ASSESMENT OF ENOXAPARINE BENEFIT ON HEALTHCARE BUDGET IN SPAIN COST SAVINGS BY THE USE OF BEMIPARIN IN THE TREATMENT OF PATIENTS WITH VENOUS THROMBOEMBOLISM IN SPAIN ESTIMATING THE ECONOMIC BURDEN OF STROKE IN SOUTH INDIA : A COST-OF-ILLNESS STUDY COST-EFFECTIVENESS ANALYSIS OF ALTERNATIVE STRATEGIES OF MONITORING FOR AMIODARONERELATED THYROID TOXICITY IN UK PRIMARY CARE COST-EFFECTIVENESS OF A NOVEL PHARMACIST GUIDED WARFARIN PHARMACOGENETIC SERVICE

Bollu Mounica

chalapathi

Masaki Shoji

Osaka Univercity of Pharmaceutical Sciences

Basil G. Bereza

University of Toronto

Kibum Kim Mariana Fernandes Lobo Seyed Hamidreza Mahmoudpour

University of Illinois at Chicago Faculty of Medicine, University of Porto

Utrecht University

Sabita Paudel Subedi

College of Medical Sciences

Pascale Dequen

University of Leicester

Dan Daneasa

Vrije Universiteit Brussel

Huei-Ru Lin

Kyoto University

Sunhee Kim

Seoul National University College of Medicine

Mireia Delgado

Sanofi

Carme Pinyol

INNOVA Strategic Consulting

Bollu Mounica

chalapathi

Vladislav Berdunov Deval Gor

University of Nottingham University of Illinois at Chicago

POSTER SESSION I: MONDAY, 9 NOVEMBER 2015, 8:45 - 14:15 MEDICAL DEVICE/DIAGNOSTICS TELEMEDICINE CONSULTATION IN THE DIFFERENTIAL DIAGNOSIS SIMPLE CONTACT DERMATITIS DUE TO INCONTINENCE AND PRESSURE SORES IN IMMOBILIZED PATIENTS WITH URINARY INCONTINENCE - CLINICAL AND PMD12 ECONOMIC ANALYSIS MODELING OF CLINICAL PATHWAYS IN THE IMPLANTATION OF CARDIOVERTER DEFIBRILLATORS FROM 2006 TO 2013 USING THE FRENCH HOSPITAL PMD123 P.M.S.I. DATABASE THE IMPACT OF SELF-MONITORING OF BLOOD GLUCOSE (SMBG) ON PRESCRIPTION COSTS IN NEWLY TREATED TYPE 2 DIABETES MELITUS (T2DM): A RETROSPECTIVE PMD131 COHORT ANALYSIS

ACCESSING THE MEDICAL DEVICES MARKET IN EGYPT AND SAUDI ARABIA: A SYSTEMATIC REVIEW OF POLICIES PMD132 AND REGULATIONS MEDICAL DEVICES: WHY DO SOME PAY MORE THAN OTHERS DO? ANALYSIS OF PRICE VARIATION IN FRENCH PMD138 PUBLIC HOSPITAL IN 2013 COSTS OF COMPRESSION THERAPY IN VENOUS LEG ULCERS IN GERMANY AND MODELLING OF THE ECONOMIC EFFECTS OF REGIONAL DISPARITIES IN PMD156 HEALTH CARE

PMD22 PMD23 PMD3

PMD45

PMD58 PMD73

PMD77

TO ACCESS INDEPENDENT RISK CAUSE OF SUDDEN CARDIAC DEATH IN HEMODIALYSIS PATIENTS IDENTIFYING THE OPTIMAL USE OF CTCS IN THE EARLY STAGING PHASE OF BREAST CANCER CYTOGENETICS AND DOPAMINE RECEPTOR (DRD2) GENE POLYMORPHISM IN SCHIZOPHRENIA PATIENTS A NEXT-GENERATION FRAMEWORK: DECIDING ON THE ROLE OF COSTS IN THE CLINICAL USE OF TARGETED GENE PANELS, EXOME AND GENOME SEQUENCING HIGHER ACCURACY OF BLOOD GLUCOSE MONITORING SYSTEMS IN TYPE 2 INSULIN TREATED DIABETIC PATIENTS IN SPAIN: CLINICAL AND ECONOMIC IMPACT COST-EFFECTIVENESS OF SCREENING FOR COLORECTAL CANCER IN ARGENTINA VALUE OF ANTIDRUG ANTIBODY SCREENING IN MODERATE-TO-SEVERE RHEUMATIOD ARTHRITIS PATIENTS WHO FAILED INITIAL TUMOR NECROSIS FACTOR-ALPHA TREATMENT

Andrey Vorobiev

Russian Society for Pharmacoeconomics and Outcomes Research

Martin Prodel

HEVA

R T Grimes

Mohamed Gad

Trinity College Dublin Centre for Health Technology Assessment (HTA) and Public Health (IZPH), Friedrich-AlexanderUniversity of ErlangenNürnberg

Mathilde Grande

Assistance PubliqueHôpitaux de Paris (AP-HP)

Mandy Gutknecht

University Medical Center Hamburg-Eppendorf Dept of Pharmacy practice, Manipal College of Pharmaceutical Sciences, Manipal University, Manipal India.

Prasanna Kumar Anne Margreet Sofie Berghuis

University of Twente

Iyer Mahalaxmi

Bharathiar University

Kjm van Nimwegen

Radboud university medical center

Aesha KhanMiron Alfredo Palacios

Universitat Pompeu Fabra Center for the Study of State and Society (CEDES)

Piyameth Dilokthornsakul

Center of Pharmaceutical Outcomes Research , Naresuan University

PMD79

PMD82

PMD9

THE COST-EFFECTIVENESS ANALYSIS OF PHILIPS MOTIVA TELEHEALTH SYSTEM: A COMPARISON BETWEEN HOME TELEMONITORING, NURSE TELEPHONE SUPPORT AND USUAL CARE IN CHRONIC HEART FAILURE A FIVE-YEAR MODEL TO ASSESS THE COST-EFFECTIVENESS OF NEW DIAGNOSTIC TESTS IN THE EARLY DIAGNOSIS OF RHEUMATOID ARTHRITIS THE CONSEQUENCES OF REPLACING THE FLEISCHNER GUIDELINES BY A SOFTWARE-BASED VOLUME DOUBLING TIME TECHNIQUE: AN EARLY-STAGE RESEARCH

Andrija S. Grustam

Erasmus University

Leander R. Buisman

Erasmus University Rotterdam

Anke Schoutrop

University of Twente

POSTER SESSION I: MONDAY, 9 NOVEMBER 2015, 8:45 - 14:15 MENTAL HEALTH

PMH11

PMH16

PMH33 PMH8

PREVALENCE OF SLEEPING PILLS CONSUMPTION AND ITS ASSOCIATION WITH DEPRESSIVE SYMPTOMS PERCENTAGE PRICE VARIATION AMONG ANTIDEPRESSANT DRUGS IN INDIAN MARKET: AN ECONOMIC PERSPECTIVE ESTIMATING THE IMPACTS OF MEDICATION ADHERENCE AND PERSISTENCE ON COSTS AND HOSPITALIZATION: THE CASE OF ATYPICAL ANTIPSYCHOTICS EFFECTIVENESS OF SUPPORTING INFORMAL CAREGIVERS OF PEOPLE WITH DEMENTIA: A SYSTEMATIC REVIEW

Katia Kodaira

Shakshi Kumari

Weiyi Ni Sophie Vandepitte

University of Sorocaba National Institute of Pharmaceutical Education and Research (NIPER) University of Southern California University of Ghent

POSTER SESSION I: MONDAY, 9 NOVEMBER 2015, 8:45 - 14:15 SENSORY SYSTEMS DISORDERS

PSS1

A PROSPECTIVE STUDY TO COMPARE SAFETY AND EFFICACY OF VARIOUS ANTI-GLAUCOMA AGENTS AND EVALUATE THE EFFECT OF AEROBIC EXERCISE ON INTRAOCULAR PRESSURE IN NEWLY DIAGNOSED PRIMARY OPEN ANGLE GLAUCOMA PATIENTS IN A TERTIARY CARE HOSPITAL

Akhil Agrawal

PSS76

SELECTIVE RETINA THERAPY

Jina MO

MUHS,NASHIK National Evidence-based Healthcare Collaborating Agency

POSTER SESSION II: MONDAY, 9 NOVEMBER 2015, 15:45 - 19:45 CANCER

PCN106 PCN109

PCN111

PCN127

THE ECONOMICS OF THE TREATMENT AND FOLLOW-UP OF PATIENTS WITH GLIOBLASTOMA COST AND COST-EFFECTIVENESS DATA ON PANCREATIC CANCER: A COMPREHENSIVE REVIEW OF THE LITERATURE MEDICAL COST ASSOCIATED WITH TREATMENT AND FOLLOW-UP OF PANTIENTS WITH HEAD AND NECK CANCER RESOURCE USE AND COST OF CHEMOTHERAPEUTIC TREATMENT FOR METASTATIC BREAST CANCER IN THE NETHERLANDS

Andreas De Paepe Nick Vandeneede

Antwerp University Antwerp University

Andreas De Paepe

Antwerp University

Xavier G. L. V. Pouwels

Maastricht University Medical Center+

PCN150 PCN152

PCN176

PCN183

PCN189

PCN190 PCN216 PCN224

PCN228

PCN235 PCN243

PCN260

PCN261

PCN265

PCN267

PCN269

PCN293 PCN316

VALUE OF IMPLEMENTATION OF PHYSICAL EXERCISE FOR CANCER SURVIVORS COST-EFFECTIVENESS ANALYSIS OF PERTUZUMAB FOR METASTATIC HER2-POSITIVE BREAST CANCER IN JAPAN ADDING BEVACIZUMAB TO SINGLE-AGENT CHEMOTHERAPY FOR THE TREATMENT OF PLATINUMRESISTANT RECURRENT OVARIAN CANCER: A COSTEFFECTIVENESS ANALYSIS OF THE AURELIA TRIAL A COST-EFFECTIVENESS ANALYSIS OF ASPIRIN IN THE PRIMARY PREVENTION OF CARDIOVASCULAR DISEASES AND COLORECTAL CANCER PHARMACOECONOMIC EVALUATION OF THE USE OF TRASTUZUMAB FOR SUBCUTANEOUS ADMINISTRATION COMPARED TO INTRAVENOUS DOSAGE FORM IN THE TREATMENT OF BREAST CANCER PHARMACOECONOMIC STUDY OF THE USE OF RITUXIMAB FOR SUBCUTANEOUS ADMINISTRATION IN THE TREATMENT OF FOLLICULAR LYMPHOMA ALTERNATIVES REGRESSIONS FOR MAPPING UTILITIES IN ONCOLOGY KNOWLEDGE ON BREAST CANCER AMONG WOMEN IN TOLNA AND BARANYA COUNTIES, HUNGARY THE WILLINGNESS OF CANCER OUTPATIENTS TO COMPLETE PATIENT-REPORTED OUTCOME MEASURES OUTSIDE OF THE CLINIC THE FINNISH VERSIONS OF THE TORONTO EXTREMITY SALVAGE SCORE AND THE MUSCULOSCELETAL TUMOR SOCIETY SCALE OF THE LOWER LIMB: A PILOT STUDY DEVELOPMENT OF A WEB-BASED QUALITY OF LIFE PORTAL FOR BREAST CANCER PATIENTS BURDEN OF METASTATIC RENAL CELL CARCINOMA IN FRANCE FROM 2008 TO 2013: ANALYSIS OF THE FRENCH NATIONAL HOSPITAL DATABASE VALUE OF ASSESSING THE BURDEN OF HOSPITALIZATIONS FOR METASTATIC MELANOMA IN THE ERA OF TARGETED THERAPIES: ANALYSIS OF THE FRENCH NATIONAL HOSPITAL DATABASE FROM 2008 TO 2013 MEASURING THE IMPORTANCE OF DECISION MAKING CRITERIA FOR ANTICANCER DRUG REIMBURSEMENT IN KOREA HOW CAN BIOSIMILARS COMPETE WITH EXISTING BIOLOGICS: UPDATE OF THE RESULTS OF A PREVIOUS STUDY ANALYSIS OF GENTUZUMAB OZOGAMICIN (GO) DRUG APPROVAL/REJECTION AMONG THREE REGULATORY AGENCIES USING GEOGRAPHIC INFORMATION SYSTEMS AND MULTICRITERIA DECISION ANALYSIS TO ADDRESS SPATIALLY EXPLICIT PROBLEMS IN HEALTHCARE POLICY DECISION MAKING QUALITATIVE ASSESSMENT OF SOCIETAL PREFERENCES FOR MARKET ACCESS OF CANCER DRUGS

Janne C. Mewes

University of Twente

Chihiro Tange

Ritsumeikan University

Elisabeth M. Schaffer

Gillings School of Global Public Health, University of North Carolina at Chapel Hill

Swee-Sung Soon

National University of Singapore

Andrew Kulikov

I.M. Sechenov First Moscow State Medical University

Andrew Kulikov Charles Sabourin Réka Vajda

Valerie Ho Jussi Petteri Repo

I.M. Sechenov First Moscow State Medical University Creativ-Ceutical University of Pécs Ontario Cancer Institute, Princess Margaret Cancer Centre

Fanny LC Loth

University of Helsinki and Helsinki University Hospital Medical University of Innsbruck

Rana Maroun

GSK France

Rana Maroun

GSK France

Anais Loubiere

College of Pharmacy, Sungkyunkwan University Faculty of Pharmacy, University Paris Descartes, Sorbonne Paris Cité

Vanessa Briceno

Massachusetts College of Pharmacy & Health Sciences

Henk Broekhuizen

University of Twente

Kim Pauwels

KU Leuven

Sunhong Kwon

PCN321 PCN53

PCN8

PCN81

PCN90

PCN97

COMPARATIVE COST-EFFECTIVENESS OF DRUGS IN EARLY VERSUS LATE STAGES OF CANCER; REVIEW OF THE LITERATURE AND A CASE STUDY IN BREAST CANCER PATIENT CHARACTERISTICS AND HEALTHCARE BURDEN OF CANCER HOSPITALIZATIONS IN THE UNITED STATES SERIOUS POST-OPERATIVE INFECTIONS INCREASE RESOURCE UTILIZATION, LENGTH OF STAY, AND INPATIENT MORTALITY IN PEDIATRIC PATIENTS UNDERGOING BRAIN TUMOR RESECTION PHARMACOECONOMIC ANALYSIS OF UROTHELIAL TRANSITIONAL CELL CANCER TREATMENT WITH VINFLUNINE IN PATIENTS RESISTANT TO THE PLATINUMBASED TREATMENT REGIMES THE COST OF RADIOTHERAPY: WHAT DO WE KNOW? A SYSTEMATIC SEARCH OF THE LITERATURE BETWEEN 1981 AND 2015 DECREASE OF PATIENT COSTS IN THE NETHERLANDS: A COST OF ILLNESS STUDY IN METASTATIC NON SMALL CELL LUNG CANCER (NSCLC)

Evgeni Dvortsin Shweta Shah

University of Groningen University of North Carolina at Charlotte

Bryce A Van Doren

University of North Carolina at Charlotte

Roza Yagudina

I.M. Sechenov First Moscow State Medical University

Noemie Defourny

Ghent university

Willem R Keusters

Utrecht University

POSTER SESSION II: MONDAY, 9 NOVEMBER 2015, 15:45 - 19:45 RESPIRATORY-RELATED DISORDERS

PRS11

PRS12

PRS28

PRS29 PRS3

PRS46

PRS62

PRS68 PRS77

CLINICAL EVALUATION OF KANAKASAVA AND SWASANANDAM GULIKA IN BRONCHIAL ASTHMA USE OF XANTHINES IN THE TREATMENT OF CHRONIC RESPIRATORY DISEASES IN SERBIA, COMPARED WITH THE SCANDINAVIAN COUNTRIES FROM 2004 TO 2013 ECONOMIC ANALYSIS OF COST OF DRUG TREATMENT INVOLVED IN THE MAINTAINANCE THERAPY OF COPD TO STUDY THE CLINICAL CHARACTERISTICS, TREATMENT PATTERN AND FACTORS ASSOCIATED WITH THE TOTAL HOSPITAL COST IN ACUTE RESPIRATORY DISTRESS SYNDROME IN TERTIARY CARE HOSPITAL RISK OF PNEUMONIA ASSOCIATED WITH THE USE OF ICS/LABA: A RETROSPECTIVE COHORT STUDY IN KOREA ECONOMIC EVALUATION OF RESPIRATORY MEDICATION THERAPY ADHERENCE CLINIC (RMTAC) ON ASTHMA PATIENTS IN MALAYSIA SYSTEMATIC LITERATURE REVIEW AND CRITICAL APPRAISAL OF THE SUITABILITY OF THE OUTCOME MEASURES USED IN THE IDIOPATHIC PULMONARY FIBROSIS COPD PERFORMANCE INDICATORS IN AN INTEGRATED CARE PROGRAM AND ITS IMPACT ON HEALTH OUTCOMES: THE RECODE CLUSTER RANDOMIZED TRIAL RESOURCE USE AND HEALTH CARE COSTS OF COPD PATIENTS AT THE END OF LIFE: A SYSTEMATIC REVIEW

Hariprasad Kuvettu

Marko Milović

PG Dept. of Kayachikitsa, Muniyal Institute of Ayurveda Medical Sciences

Shakshi Kumari

Faculty of Medicine National Institute of Pharmaceutical Education and Research (NIPER)

Aanchal Sharma

Manipal University

JeeHye Park

Ewha Womans University

Yee Vern Yong

Universiti Sains Malaysia

Irlene Shen

The University of Yorl

Melinde R.S. Boland

Erasmus University Rotterdam

Kristof Faes

University of Ghent

PRS81

PHYSICIANS' PRESCRIBING PATTERN FOR TUBERCULOSIS: EVIDENCES FROM COMMUNITY PHARMACIES IN PUNJAB, PAKISTAN

Muhammad Waseem Iqbal

Faculty of Law, Universiti Malaya

POSTER SESSION II: MONDAY, 9 NOVEMBER 2015, 15:45 - 19:45 URINARY/KIDNEY DISORDERS

PUK1

PUK28

PUK6

CYCLOSPORINE IS NOT THE DRUG OF CHOICE FOR RENAL TRANSPLANTED PATIENTS AND INCREASES THE RISK OF CARDIOVASCULAR AND CEREBROVASCULAR ACCIDENTS DOES OUT-PATIENT MEDICAL INSURANCE POLICY WORK AMONG CKD PATIENTS IN NON-DIALYSIS PHASES? EVIDENCE FROM TWO SAMPLE CITIES IN CHINA PREVALENCE OF CHRONIC KIDNEY DISEASE IN INDIA: A SYSTEMATIC REVIEW AND META-ANALYSIS OF OBSERVATIONAL STUDIES

Javeria Fazal

Uinversita' della Calabria

Jingxian Wu

Xi'an Jiaotong University National Institute of Pharmaceutical Education and Research (NIPER)

Rajiv Ahlawat

POSTER SESSION III: TUESDAY, 10 NOVEMBER 2015, 8:45 - 13:45 HEALTH CARE USE & POLICY STUDIES

PHP12

PHP122

PHP15 PHP151

PHP152 PHP153

PHP159

EPIDEMIOLOGICAL DATA PRESENTED IN GERMAN BENEFIT ASSESSMENTS – A COMPARISON BETWEEN PHARMACEUTICAL COMPANIES AND G-BA CHANGES IN THE PRICES OF REFERENCE BIOTECHNOLOGY PRODUCTS BY THE PENETRATION OF BIOSIMILARS INTO THE TURKISH PHARMACEUTICAL MARKET THE IMPACT OF THE INCREASING PENETRATION OF ONPATENT MEDICINES ON THE GREEK PHARMACEUTICAL MARKET USE OF HEALTH SERVICES IN BRAZIL: A SYSTEMATIC REVIEW AND META-ANALYSIS OF PREVALENCE STUDIES HURDLES THAT IMPEDE ECONOMIC EVALUATIONS OF HEALTH CARE INTERVENTIONS TESTED BY GENERAL PRACTITIONERS IN FLANDERS: A QUALITATIVE STUDY ASSOCIATION BETWEEN DEPRESSION AND DISCONTINUATION WITH ANTIDIABETIC DRUGS A STUDY OF KNOWLEDGE, ATTITUDE AND PRACTICE OF COMMUNITY PHARMACISTS TOWARDS ADVERSE DRUG REACTION REPORTING & MONITORING

INTRA- AND EXTRA-ORGANIZATIONAL FACTORS AFFECTING PHP166 COMMUNITY PHARMACY PERFORMANCE VALIDATION OF PERIODIC SAFETY UPDATE REPORTING SYSTEM IN A TERTIARY CARE TEACHING HOSPITAL USING ADVERSE DRUG REACTION MONITORING OF THREE PHP173 COMMONLY PRESCRIBED DRUGS THE RELATIONSHIP BETWEEN KNOWLEDGE AND PERFORMANCE: THE CASE OF IRAN COMMUNITY PHP174 PHARMACIES DISCOUNT DISTRIBUTION ANALYSIS OF ORIGINAL PHP190 MEDICINES WHICH HAS NO GENERICS IN TURKEY

Zohaira El Malahi

Cologne University of Applied Sciences

Esin Tuna

Hacettepe University

Nikolaos George Manias Elizete Araújo

MINTE Federal University of Amazonas

Janne Schepers

KU Leuven

Carlotta Lunghi

Laval University

MS Srikanth Maryam Rangchian

JSS College of Pharmacy, Mysore, JSS University Shahid Beheshti university of medical Sciences, School of Pharmacy

Maryam Rangchian

Manipal College of Pharmaceutical Sciences, Manipal University Shahid Beheshti university of medical Sciences, School of Pharmacy

Esin Tuna

Hacettepe University

Alkesh Lokhande

PHP203 PHP204

PHP222 PHP231 PHP257

PHP269 PHP278 PHP284

PHP290

PHP292

PHP31

PHP311 PHP325

PHP328

PHP33

PHP333

PHP335

ATC1 GROUP DISCOUNT DISTRIBUTION ANALYSIS OF ORIGINAL MEDICINES WHICH HAS NO GENERICS IN TURKEY IMPACT OF HEALTHCARE REFORMS ON PRICING AND REIMBURSEMENT IN TURKEY METHODOLOGICAL GAPS IN THE ASSESSMENT OF THE UTILITY AND BURDEN OF RISK MINIMISATION INTERVENTIONS BUILDING A BRIDGE BETWEEN CLINICAL EVIDENCE RESEARCH AND PATIENT PREFERENCE RESEARCH COMPARISON OF ECONOMIC EVALUATION BETWEEN THREE MAJOR HTA AGENCIES. IS THERE A FRENCH TOUCH? CURRENT PERCEPTION OF UPCOMING COSTEFFECTIVENESS REQUIREMENTS IN JAPAN: A SURVEY ON THE PERSPECTIVE OF PHARMACEUTICAL INDUSTRY EUNETHTA MEMBERS: WHAT ARE THEIR ROLES WITHIN THE NATIONAL SETTING? TRENDS IN SELF-RATED HEALTH STATUS AMONG ADULTS IN GREECE (2002-2015) ASSESSMENT OF DRUG USE PATTERN USING WHO PRESCRIBING AND PATIENT CARE INDICATORS IN A REFERRAL HOSPITAL IN ETHIOPIA ASSESSMENT OF DRUG PRESCRIBING AMONG PREGNANT WOMEN ATTENDING ANTENATAL OUT PATIENT DEPARTMENT OF A REFERRAL HOSPITAL IN ETHIOPIA THE END OF THE EXCEPTIONAL FINANCING OF ERYTHROPOIESIS-STIMULATING AGENTS IN FRENCH HOSPITALS: WHAT ARE THE IMPACTS FOR PUBLIC HOSPITALS OF PARIS ? USING FINANCIAL INCENTIVES TO MOTIVATE STAIR USE IN A WORKPLACE SETTING: RESULTS FROM A RANDOMIZEDCONTROLLED TRIAL DEVELOPMENT OF HOSPITAL-BASED HTA UNIT PROCESSES IN THE CZECH HOSPITAL ENVIRONMENT THE INFLUENCE OF “HAS” HAUTE AUTORITE DE SANTE IN THE REIMBURSEMENT DECISIONS IN FRANCOPHONE COUNTRIES: THE CASE OF NORTH AFRICA REGION EVALUATION OF WHO/INRUD PRESCRIBING INDICATORS AND PRESCRIBING TREND OF ANTIBIOTICS IN ACCIDENTS AND EMERGENCY DEPARTMENT, BAHAWAL VICTORIA HOSPITAL, BAHAWALPUR, PAKISTAN INTRODUCTION OF FORMAL RISK SHARING AGREEMENTS (RSA): A PROMISING SOLUTION FOR SUSTAINABLE AND PREDICTABLE PHARMACEUTICAL EXPENDITURES IN BULGARIA COMPARISON OF PHARMACEUTICAL PRICING AND REIMBURSEMENT SYSTEMS IN TURKEY AND CERTAIN OTHER COUNTRIES

NEED FOR NEW PHARMACOECONOMICS POLICY FOR PHP342 REGULATING PRICES OF MEDICAL DEVICES IN INDIA PRICING AND REIMBURSEMENT POLICIES OF TURKEY AND PHP343 UKRAINE

Kagan Atikeler

Hacettepe University

Kagan Atikeler

Hacettepe University

Nicolas Thurin Henk Broekhuizen Gabriel Guigand

Université de Bordeaux University of Twente

Hyunchung, Ray Kim Sandra Diekmann Dionisios Kyriopoulos

Université Paris-Dauphine The University of Tokyo, Graduate School of Public Policy The National Healthcare Institute (ZIN) National School of Public Health

Befikadu Legesse

Karolinska Institutet

Befikadu Legesse

Karolinska Institutet

Carole Therasse

General Agency of Equipment and Health Products (AGEPS), AP-HP

Y Y Guan

National University of Singapore

Martin Zavadil

Motol University Hospital

Amine Aissaoui

Paris dauphine University

Muhammad Azeem

The Islamia University of Bahawalpur

Martin Petrov

MSD Bulgaria

Kagan Atikeler

Prashant Soni

Hacettepe University Delhi Institute of Pharmaceutical Sciences & Research

Kagan Atikeler

Hacettepe University

HEALTH PROFFESSIONALS INVOLVEMENT IN POLITICS A MEANS TO IMPROVING HEALTHCARE DELIVERY AND HEALTHCARE LEGISLATIONS FOR HEALTHCARE SEEKERS IN PHP344 AFRICA IMPACT OF DESICION MAKING BASED ON QUALITY OF THE EARLY WARNING INDICATORS IN COLOMBIA DURING 2013 – 2014 BETWEEN PRIVATE AND PUBLIC IPS AND THE PHP355 QUANTITY OF AFFILIATES BY REGIMEN EXTERNAL REFERENCE PRICING FROM THE PERSPECTIVE OF PHP36 SLOVENIA USING DECISION MAKING CLINICAL SCENARIOS TO APPRAISE PREFERENCES AND VALUE JUDGMENTS IN PHP37 HEALTH TECHNOLOGY ASSESSMENT (HTA) ANALYSIS OF THE REPORTS OF THE NATIONAL COMMITTEE FOR TECHNOLOGY INCORPORATION (CONITEC) IN THE PHP49 BRAZILIAN PUBLIC HEALTH SYSTEM (SUS), 2012-2015 USE OF INCREMENTAL COST-EFFECTIVENESS RATIO (ICER) IN RECOMMENDING TECHNOLOGIES INCORPORATION IN PHP50 THE BRAZILIAN PUBLIC HEALTH SYSTEM (SUS), 2012-2015 ASSESSMENT OF WHO/INRUD CORE DRUG USE INDICATORS IN TWO TERTIARY CARE HOSPITALS OF PHP59 BAHAWALPUR, PUNJAB, PAKISTAN THE IMPACT OF CONSUMER-DIRECTED HEALTH PLANS ON PHP6 PRICE SHOPPING ASSESSING EQUITY OF HEALTH SERVICE UTILIZATION OF RURAL RESIDENTS IN CHINA: A CASE STUDY OF Z COUNTY, PHP64 SHAANXI PROVINCE ASSESSING EQUITY OF HEALTH SERVICE UTILIZATION OF URBAN RESIDENTS IN CHINA: A CASE STUDY OF B CITY, PHP65 SHAANXI PROVINCE THE INTERTEMPORAL CHANGES OF HEALTH SERVICES UTILIZATION DURING THE LAST DECADE: THE CASE OF PHP66 AUSTERITY INFLICTED ON GREECE DOES CHINA'S NEW MEDICAL REFORM IMPROVE HEALTH EQUITY OF RURAL RESIDENTS? EVIDENCE FROM HOUSEHOLD SURVEYS BEFORE AND AFTER THE IMPLEMENTATION OF NEW MEDICAL REFORM IN SHAANXI PHP68 PROVINCE, CHINA A NEW METHODOLOGY TO DEFINE THE SCOPE OF THE PHP7 FRENCH « LISTE-EN-SUS » UNDERSTANDING THE UNDERUTILISATION OF EVIDENCE FROM ECONOMIC EVALUATIONS IN HEALTHCARE: A MIXED PHP73 METHODS DESIGN DOES THE ATU PROCESS HAVE AN IMPACT ON TIME TO PHP74 MARKET LAUNCH? THE RELATIONSHIP BETWEEN SOCIOECONOMIC PHP76 CHARACTERISTICS AND SELF-RATED HEALTH IN GREECE ASSESSING THE EFFICIENCY OF THE LONG-TERM CARE PHP78 HOSPITAL UNITS IN HUNGARY BETWEEN 2006 AND 2013 ORGANS-ON-CHIPS: EXPLORING THE UTILITY OF BIOSYNTHESISED ORGAN TISSUE TO IMPROVE EFFICIENCY PHP81 OF THE DRUG DEVELOPMENT PROCESS

Augustine Obichukwu Odenigbo Jose Armin Ordoñez Castillo

University of Nigeria Nsukka

Nika Mardetko

Universidad de los Andes University of Ljubljana, Faculty of Pharmacy

Luiz Santoro Neto

Federal University of São Paulo

Tania Y Yuba

University of Sao Paulo

Tania Y Yuba

University of Sao Paulo

Muhammad Rehan Sarwar Xinke Zhang

The Islamia University of Bahawalpur University of Southern California

Jingxian Wu

Xi'an Jiaotong University

Jingxian Wu

Xi'an Jiaotong University

Antonios Charonis

National School of Public Health

Jingxian Wu Anne-France Motte

Xi'an Jiaotong University

Gregory Merlo Delphine Houzelot Antonios Charonis

French ministry of Health Queensland University of Technology PRIORITIS Market Access National School of Public Health

Tímea Csákvári

University of Pécs

H.H.T Middelkamp

University of Twente

PHP87

A COMPARISON OF KEY COMPONENTS OF THE HTA CORE MODEL AND THE AMCP FORMAT HEALTH SERVICES UTILIZATION BY DENGUE PATIENT IN BRAZIL, 2012 – 2013: A MULTICENTER STUDY

Elisabeth M. Oehrlein Ana Laura Sene Amancio Zara

PHP99

BIOSIMILARS ENTRY AND PRICE DEVELOPMENT IN EUROPE

Elena Dacheva

PHP84

University of Maryland, School of Pharmacy Universidade Federal de Goias Erasmus University Rotterdam

POSTER SESSION III: TUESDAY, 10 NOVEMBER 2015, 8:45 - 13:45 INFECTION

PIN11

PIN22

PIN28

PIN32

PIN33

PIN37

PIN39

PIN4 PIN66

PIN82 PIN86

PIN87 PIN94

ESTIMATION OF THE RELATIVE EFFICACY OF LICENSED REGIMENS FOR GENOTYPE-1 HCV INFECTION USING A MIXED TREATMENT COMPARISON HEALTH ECONOMIC IMPACT OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN FINNISH HOME CARE CUSTOMERS ≥50 YEARS WITH UNDERLYING CHRONIC MEDICAL CONDITIONS A SYSTEMATIC LITERATURE REVIEW OF THE ECONOMIC IMPLICATIONS OF ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS (ABSSSIS) COMPARISON OF DIRECT HOSPITALIZATION COSTS AND LENGTH OF STAY IN CARBAPENEM RESISTANT VERSUS CARBAPENEM SENSITIVE KLEBSIELLA PNEUMONIAE INFECTIONS IN A TERTIARY CARE HOSPITAL DIRECT COSTS AND LENGTH OF STAY IN PATIENTS WITH METHICILLIN RESISTANT VERSUS METHICILLIN SENSITIVE STAPHYLOCOCCUS AUREUS INFECTION IN A TERTIARY CARE HOSPITAL IN INDIA HEALTH-ECONOMIC EVALUATION OF CLOSTRIDIUM DIFFICILE INFECTION (CDI) AND EPIDEMIOLOGY IN ENGLAND AND MERSEYSIDE POTENTIAL HEALTH AND ECONOMIC IMPACT OF INTRODUCING A DENGUE VACCINE IN MALAYSIA: ASSESSMENT USING DYNAMIC TRANSMISSION MODELLING THE USE OF SINGLE-ARM EVIDENCE IN THE COMPARATIVE EFFICACY OF INTERFERON-FREE ANTIVIRALS FOR TREATMENT-NAïVE HEPATITIS C GENOTYPE 1 COST EFFECTIVENESS OF BEDAQUILINE FOR PATIENTS WITH MULTI-DRUG RESISTANT TUBERCULOSIS IN SOUTH KOREA ADHERENCE TO ANTIRETROVIRAL THERAPY AMONG PATIENTS LOST-TO-FOLLOW UP: A CASE OF AN HIV CLINIC IN A PRIVATE-FOR-PROFIT HEALTH FACILITY IN KAMPALA, UGANDA KNOWLEDGE, ATTITUDE AND PERCEPTION OF POLIO (POLIOMYELITIS) AMONG GENERAL PUBLIC IN PAKISTAN EFFECT OF PHARMACIST INTERVENTIONS AND PATIENT REPORTED OUTCOMES ON HIGHLY ACTIVE ANTIRETROVIRAL THERAPY COUNSELING IN INDIAN HIV POSTIVE PATIENTS : A PROSPECTIVE STUDY INDISCRIMINATE PRESCRIPTION OF ANTIBIOTICS AND AN URGENT NEED OF LEGISLATION- A SURVEY FROM PAKISTAN

Emma Gray

School of Medicine, Trinity College Dublin

Petri T Mankinen

ESiOR Oy

Fabian Degener University of Groningen

Zoya Ahmed

Manipal College of Pharamaceutical Sciences

Nishitha N Prabhu

Manipal College of Pharmaceutical sciences, Manipal University

Carina A Nakamura

University of Liverpool

Hui Yee Yeo

Universiti Sains Malaysia

Eric Druyts Hae-Young PARK

University of British Columbia Kyungpook National University

Ronald Anguzu Muhammad Waseem Iqbal

Radhakrishnan Rajesh Muhammad Waqas

Makerere University School of Public Health Faculty of Law, Universiti Malaya MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES, MANIPAL UNIVERSITY Abdul Wali Khan University

POSTER SESSION IV: TUESDAY, 10 NOVEMBER 2015, 15:15 - 19:15 DIABETES/ENDOCRINE DISORDERS

PDB10

PDB104 PDB109

PDB110 PDB111 PDB123 PDB124

PDB126

PDB127

PDB130

PDB134

PDB24

PDB27

PDB30 PDB34

PDB37

INDIRECT COMPARISON TO EVALUATE THE EFFICACY AND SAFETY OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS (DPP4I) AND SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS (SGLT2I) ADDED TO INSULIN THERAPY IN TYPE 2 DIABETES ASSESSMENT OF HEALTH RELATED QUALITY OF LIFE (HRQL) USING EQ-5D IN TYPE 2 DIABETES MELLITUS PATIENTS IN A UNIVERSITY TEACHING HOSPITAL WILLINGNESS TO PAY FOR ONE QUALITY ADJUSTED LIFE YEARS IN PATIENTS WITH DIABETES MOBILE PHONE USE AND WILLINGNESS TO PAY FOR SMS FOR DIABETES IN BANGLADESH WILLINGNESS TO PAY FOR QUALITY-ADJUSTED LIFE YEARS IN PATIENTS WITH DIABETE IMPROVING THE SYSTEM OF HEALTHCARE PROVISION FOR PATIENTS WITH HYPOTHYROIDISM IN UKRAINE BURDEN OF DISEASE OF DIABETES MELLITUS TYP-2 IN AUSTRIA HEALTHCARE USE AND EXPENDITURE FOR DIABETES IN BANGLADESH: A MATCHED-CASE-CONTROL STUDY EPIDEMIOLOGY AND COSTS OF PERIPHERAL ARTERIOPATHY IN DIABETIC PATIENTS: A POPULATIONBASED STUDY COMPLEMENTARY AND ALTERNATIVE MEDICINES (CAM) AMONG DIABETES PATIENTS: A PROSPECTIVE STUDY FROM PAKISTAN EFFECT OF PATIENT-EDUCATION ON HEALTH-RELATED QUALITY OF LIFE OF DIABETIC FOOT ULCER PATIENTS IN A TERTIARYCARE HOSPITAL BUDGET IMPACT ANALYSIS OF LONG-ACTING INSULIN ANALOGUES IN THE PERSPECTIVE OF BRAZILIAN PUBLIC HEALTH SYSTEM IMPACT OF NURSE-LED TELECOACHING ON THE ANNUAL HEALTHCARE UTILIZATION AND COSTS IN PEOPLE WITH TYPE 2 DIABETES IN BELGIUM. WITHIN-TRIAL ANALYSIS OF HEALTH INSURANCE DATA COST ANALYSIS STUDY OF ANTI-DIABETIC FIXED DOSE COMBINATION DRUGS: AN INDIAN SCENARIO DIRECT COST OF UNCOMPLICATED HYPOTHYROIDISM DURING PREGNANCY AND CHILDBED IN CZECH REPUBLIC COST OF ILLNESS STUDY OF TYPE 2 DIABETES MELLITUS IN THE NEWLY ESTABLISHED DIABETOLOGY OUTPATIENT FACILITY IN THE CZECH REPUBLIC

Jeong-Hwa Yoon

Marilies Bauer Sheikh Mohammed Shariful Islam

Seoul National University College of Medicine Manipal College of Pharmaceutical Sciences, Manipal University shahid beheshti university of medical science Ludwig-MaximiliansUniversität (LMU), Munich, Germany shahid beheshti university of medical science Ivan Horbachevsky Ternopil State Medical University Institute for Pharmaeconomic Research Ludwig-MaximiliansUniversität (LMU), Munich, Germany

Roberta Ciampichini

University of Milano Bicocca

Muhammad Waseem Iqbal

Faculty of Law, Universiti Malaya

Sonal Sekhar Miraj

Manipal College of Pharmaceutical Sciences

Fernanda O Laranjeira

University of Brasilia

Yogesh Vohra Najmeh Moradi Sheikh Mohammed Shariful Islam Najmeh Moradi Iuliia Vadziuk

Irina Odnoletkova

Jana Bartakova

University of Leuven National Institute of Pharmaceutical Education and Research (NIPER) 1st Faculty of Medicine Charles University in Prague

Ondrej Gajdos

Czech Technical University in Prague

Salman Hussain

POSTER SESSION IV: TUESDAY, 10 NOVEMBER 2015, 15:15 - 19:15 GASTROINTESTINAL DISORDERS

PGI18 PGI26

PGI33

PGI34

PGI36

THE COST-EFFECTIVENESS OF REFERRING PATIENTS WITH IRRITABLE BOWEL SYNDROME TO A GASTROENTEROLOGIST IN THE UK COST-EFFECTIVENESS OF EVEROLIMUS IN LIVER TRANSPLANTATION COST-EFFECTIVENESS AND COST-UTILITY OF HOME-BASED HYPNOTHERAPY USING COMPACT DISC VERSUS INDIVIDUAL HYPNOTHERAPY BY A THERAPIST FOR PEDIATRIC IRRITABLE BOWEL SYNDROME AND FUNCTIONAL ABDOMINAL PAIN (SYNDROME) ECONOMIC EVALUATION OF FECAL MICROBIOTA TRANSPLANTATION FOR THE TREATMENT OF RECURRENT CLOSTRIDIUM DIFFICILE INFECTION IN AUSTRALIA ECONOMIC EVALUATION OF INFLIXIMAB FOR TREATMENT OF REFRACTORY ULCERATIVE COLITIS IN IRAN: COSTEFFECTIVENESS ANALYSIS

Caroline Canavan Luana Regina B C Mendes

University of Nottingham Sao Paulo University

M. van Barreveld

Academic Medical Centre

Gregory Merlo

Queensland University of Technology

Najmeh Moradi

shahid beheshti university of medical science

POSTER SESSION IV: TUESDAY, 10 NOVEMBER 2015, 15:15 - 19:15 MUSCULAR-SKELETAL DISORDERS ESTIMATING THE MONETARY VALUE OF RELIEF OF TENNIS ELBOW: A CONTINGENT VALUATION STUDY OF PMS113 WILLINGNESS-TO-PAY IDENTIFICATION OF OSTEOPOROSIS & CHRONIC INFLAMMATORY RHEUMATIC DISEASE IN FRENCH CLAIMS PMS19 DATA HEALTH CARE RESOURCE UTILIZATION AND DIRECT MEDICAL COST FOR PATIENTS WITH OSTEOPOROTIC PMS45 FRACTURES IN TIANJIN, CHINA PREDICTING THE FUTURE ECONOMIC BURDEN OF HIP FRACTURES IN NORWAY-THE IMPACT OF PMS50 EPIDEMIOLOGICAL UNCERTAINTY EXPECTED LIFETIME NUMBERS, RISKS, AND BURDEN OF PMS53 FRACTURES FOR 50-YEAR OLD CHINESE WOMEN COST-EFFECTIVENESS ANALYSIS OF CANACINUMAB IN THE TREATMENT OF PATIENTS SUFFERING FROM SYSTEMIC PMS72 JUVENILE IDIOPATHIC ARTHRITIS IN RUSSIAN FEDERATION TELEREHABILITATION AFTER TOTAL KNEE REPLACEMENT: PRELIMINARY COST-EFFECTIVENESS ANALYSIS OF AN PMS75 INNOVATIVE DEVICE COMPARATIVE EFFECTIVENESS AND COST-EFFECTIVENESS OF GENERIC ALENDRONATE, RISENDRONATE, DENOSUMAB AND ZOLENDRONIC ACID FOR SECONDARY PREVENTION OF FRAGILITY FRACTURES - PERLIMINAY PMS84 RESULTS

Michelle Jessica Pereira

University of Queensland

Manon Belhassen

University of Lyon

Jing Wu

Tianjin University

Yawen Jiang

Norwegian University of Science and Technology University of Southern California

Roza Yagudina

I.M. Sechenov First Moscow State Medical University

Francesco Fusco

Scuola Superiore Sant’Anna

Gunhild Hagen

Norwegian University of Science and Technology

Gunhild Hagen

POSTER SESSION IV: TUESDAY, 10 NOVEMBER 2015, 15:15 - 19:15 SYSTEMIC DISORDERS/CONDITIONS

PSY107 PSY110 PSY112

PSY115

PSY131

PSY14

PSY15 PSY21

PSY29

PSY3 PSY50

PSY55

PSY57

PSY7

PSY70

PSY71

COMPARATIVE ANALYSIS OF THE REIMBURSEMENT LANDSCAPE OF ORPHAN DRUGS ON AN INTERNATIONAL LEVEL HORIZONTAL VS. VERTICAL EQUITY: MARKET ACCESS OF ORPHAN DRUGS IN FRANCE AND UK ECONOMIC IMPACT OF THE END OF THE MARKET EXCLUSIVITY FOR ORPHAN DRUGS THE FEASIBILITY OF APPLYING DEFINITIONS OF PERSISTENT OPIOID UTILISATION TO QUANTIFY THE PERSISTENCY OF TRAMADOL USERS A COMPARISON OF THE SCIENTIFIC AND SOCIAL VALUE JUDGMENTS MADE DURING HTA DECISION PROCESSES FOR ORPHAN DRUGS IN ENGLAND, FRANCE, SCOTLAND AND SWEDEN COST EFFECTIVENESS OF MULTIDISCIPLINARY PAIN MANAGEMENT SERVICES FOR CHRONIC BACK PAIN: SYSTEMATIC REVIEW PREVALENCE OF ANTIDEPRESSANTS PRESCRIBED TO TRAMADOL USERS IN THE UK PRIMARY CARE SETTING - A PRESCRIPTION SEQUENCE SYMMETRY ANALYSIS PREVALENCE OF TRANSTHYRETIN FAMILIAL AMYLOID POLYNEUROPATHY IN PORTUGAL BUDGET IMPACT ANALYSIS OF CANACINUMAB IN THE TREATMENT OF PATIENTS WITH MUCKLE–WELLS SYNDROME IN THE RUSSIAN FEDERATION EFFICACY OF THE MICA ANTIBODY FOR TRANSPLANT PATIENTS AMBULATORY MEDICINES COST WITH TRANSTHYRETIN FAMILIAL AMYLOID POLYNEUROPATHY IN PORTUGAL RE-EVALUATING THE COST-EFFECTIVENESS OF SCREENING FOR CONGENITAL ADRENAL HYPERPLASIA (CAH): THE SENSITIVITY TO CHOICE OF DISTRIBUTIONS IN PROBABILISTIC SENSITIVITY ANALYSES (PSAS) THE COST-EFFECTIVENESS OF BIOLOGICS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASES: A SYSTEMATIC REVIEW

GUILLAIN-BARRE SYNDROME: CLINICAL PRESENTATION, TREATMENT PATTERN AND OUTCOME COST UTILITY ANALYSIS COMPARING STRATEGIES FOR INITIAL TREATMENT OF RHEUMATOID ARTHRITIS USING PUBLIISHED OUTCOMES: ECONOMIC LESSONS FROM THE TEAR TRIAL COST-EFFECTIVENESS ANALYSIS OF TOCILIZUMAB SUBCUTANEOUS AS FIRST LINE BIOLOGIC MONOTHERAPY FOR RHEUMATOID ARTHRITIS MANAGEMENT IN GREECE

Sara Nazha Daria Korchagina Marguerite Kandel

University of Montreal University of Paris-Sud AGEPS

Teng-Chou Chen

University of Nottingham

Elena Nicod

London School of Economics and Political Science

Saja Almazrou

university of Nottingham

Teng-Chou Chen Mónica Inês

University of Nottingham Instituto de Medicina Molecular

Mónica Inês

I.M. Sechenov First Moscow State Medical University National Evidence-based Healthcare Collaborating Agency Instituto de Medicina Molecular

Abdulaziz Alzarea

MCPHS University

Roza Yagudina

Jina MO

Saara Huoponen

Kunhikatta Vijayanarayana

University of Helsinki Dept. of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal University

Paul Adam Fuchs

University of Texas School of Public Health

Filippos Tarantilis

National School of Public Health

PSY73 PSY79

PSY8 PSY81 PSY86 PSY87

PSY95 PSY97

COST-EFFECTIVENESS OF BARIATRIC SURGERY FOR THE TREATMENT OF OBESITY IN AUSTRALIA TRANSTHYRETIN FAMILIAL AMYLOID POLYNEUROPATHY IMPACT ON HEALTH-RELATED QUALITY OF LIFE SYSTEMATIC REVIEW OF ECONOMIC EVALUATIONS IN MULTIDISCIPLINARY PAIN MANAGEMENT SERVICES FOR MANAGING PEOPLE WITH FIBROMYALGIA OR CHRONIC WIDESPREAD PAIN SOCIAL UTILITY VALUES FOR PEMPHIGUS VULGARIS AND FOLIACEUS: A COMPOSITE TIME TRADE-OFF STUDY CLUSTERING HEALTH STATUS AMONG ADULTS WITH HEMOPHILIA USING SF-12 HEALTH SURVEY OPIOIDS SWITCH IN CHRONIC PAIN: IMPACT ASSESSMENT USING ELECTRONIC HEALTH RECORDS THE RELATIONSHIP BETWEEN DISEASE SEVERITY AND QUALITY OF LIFE IN PATIENTS WITH MODERATE TO SEVERE PSORIASIS HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH TRANSTHYRETIN FAMILIAL AMYLOID POLYNEUROPATHY

Ryan Salton Mónica Inês

Shiekha AlAujan

Griffiths University / City University London Instituto de Medicina Molecular

Xiaoli Niu

University of Nottingham Corvinus University of Budapest University of Southern California

Silvia Ussai

Medigenia BioHighTech FVG

K Geale

Umeå University Instituto de Medicina Molecular

Fanni Rencz

Mónica Inês

POSTER SESSION V: WEDNESDAY, 11 NOVEMBER 2015, 8:45 - 13:45 INDIVIDUAL'S HEALTH

PIH1 PIH14

PIH20

PIH22

PIH31 PIH36

PIH4

PIH49 PIH5 PIH55

A COST-EFFECTIVENESS ANALYSIS OF HOSPITAL PHARMACIST REVIEW IN OLDER PATIENTS COST STUDY OF ASSISTED REPRODUCTIVE TECHNOLOGIES IN UKRAINE POPULATION COST-EFFECTIVENESS OF A PARENTING PROGRAM FOR THE TREATMENT OF CONDUCT DISORDERS: A MODELLING STUDY TO ASSIST PRIORITY SETTING IN AUSTRALIA MEDICAL TERMINATION OF PREGNANCY PROVIDED BY NURSE-MIDWIFES OR PHYSICIANS IN A HIGH RESOURCE SETTING: A COST-EFFECTIVENESS ANALYSIS INCONSISTENCY IN THE VALUATIONS OF EuroQol EQ-5D5L HEALTH STATES IN CHINA WAS MORE RELATED TO INTERVIEWER AND TO INTERVIEW PROCESS THAN TO RESPONDENTS’ CHARACTERISTICS TIME TRADE-OFF UTILITY VALUES IN MILD AND SEVERE PRIMARY DYSMENORRHEA PRACTICES OF SUBSTANCE ABUSE AND RISKY SEXUAL BEHAVIOR AMONG ADAMA SCIENCE AND TECHNOLOGY UNIVERSITY UNDERGRADUATE STUDENTS IN 2012/13 ACADEMIC YEARS THE IMPORTANCE OF THE COMMUNICATOR FOR AN INTEGRATED CARE PROGRAM - A COMPARATIVE PREFERENCE ANALYSIS WITH DISCRETE CHOICE EXPERIMENTS EXAMINING PRESCRIBING PATTERNS IN OLDER PATIENTS WITH ACUTE ILLNESS THERAPEUTIC REFERENCE PRICING SYSTEM IN SLOVENIA FROM THE PATIENTS' PERSPECTIVE

Stephen Byrne Khrystyna-Olha Horbachevska

University College Cork Danylo Halytsky Lviv National Medical University

Filipa Sampaio

Uppsala University

Susanne Sjöström

Karolinska Institutet

Fanni Rencz

Erasmus University Rotterdam Corvinus University of Budapest

Tadesse Mekonnen

Adama Science and Technology University

Zhihao Yang

Susanne Bethge Michael McCarthy Nika Mardetko

Hochschule Neubrandenburg University College Cork University of Ljubljana, Faculty of Pharmacy

PIH64 PIH68

PIH76

PIH8

PIH84

PIH88

SATISFACTION WITH LIFE OF GENERAL POPULATION OF PAKISTAN. A NATION WIDE SURVEY VALIDITY AND RESPONSIVENESS OF PREFERENCE BASED MEASURES: A CRITICAL OVERVIEW OF REVIEWS CHILDREN'S MEDICATION IN THE NORDIC COUNTRIES – SURVEY ON NATIONAL ADMINISTRATIVE REGISTER DATA PREVALENCE OF SELF-MEDICATION AND ITS REASON AMONG PHARMACY STUDENTS IN INDIA: A CROSSSECTIONAL STUDY STIMULANT USE AND CARDIOVASCULAR RISK AMONG CHILDREN AND ADOLESCENTS WITH ADHD: WHAT PRODUCT LABELING DOES, OR DOES NOT, TELL US THE ASSOCIATION OF EARLY EXPOSURE TO PHENOLS AND NEURO-BEHAVIOR DEVELOPEMNT IN SCHOOL-AGED CHILDREN

Azfar Akram Aureliano Paolo Finch

Disa Långström

Salman Hussain

Jan Sieluk

I-Jen WANG

University of Balochistan University of Sheffield Pharmaceutical Sciences Laboratory, Åbo Akademi University National Institute of Pharmaceutical Education and Research (NIPER) University of Maryland School of Pharmacy Graduate School National Taiwan University/Taipei City Hospital,Jen-Ai branch

POSTER SESSION V: WEDNESDAY, 11 NOVEMBER 2015, 8:45 - 13:45 NEUROLOGICAL DISORDERS

PND12

PND14 PND3

PND31

PND42 PND46

PND5

PND72

CHARACTERISTICS ASSOCIATED WITH ANNUAL BLEEDING FREQUENCY AMONG HEMOPHILIA PATIENTS IN THE UNITED STATES VARIATION IN STATE-LEVEL VS. NATIONAL INCIDENCE IN RARE GENETIC DISEASE: A MONTE CARLO SIMULATION TO EXAMINE SAMPLING VARIATION AS A PRIMARY EXPLANATION IN CONGENITAL ADRENAL HYPERPLASIA TWENTY-YEAR TRENDS IN DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE HEALTH CARE RESOURCE UTILIZATION AND DIRECT MEDICAL COSTS AMONG PATIENTS WITH EPILEPSY IN TIANJIN, CHINA EXPLORING COST-EFFECTIVENESS HETEROGENEITY BY STATE: USING STATE-LEVEL VS. NATIONAL DISEASE INCIDENCE IN NEWBORN SCREENING (NBS) COSTEFFECTIVENESS ANALYSIS OF CONGENITAL ADRENAL HYPERPLASIA (CAH) COST-EFFECTIVENESS ANALYSIS OF GLYBERA FOR THE TREATMENT OF LIPOPROTEIN LIPASE DEFICIENCY IDNTIFICATION OF CHROMOSOMAL ALTERATION AND ASSOCIATION STUDY OF MTHFR GENE MUTATIONS IN AUTISM PREFERENCES OF PATIENTS WITH MULTIPLE SCLEROSIS FOR ATTRIBUTES OF DISEASE MODIFYING DRUGS IN DECISION-MAKING: A NOMINAL GROUP TECHNIQUE AND BEST-WORST SCALING

Christina X Chen

Alhanoof Alnafesah

University of Southern California

Maya L. Hanna

MCPHS University University of Maryland, School of Pharmacy

Jing Wu

Tianjin University

Amal Alotaibi Xue Han

MCPHS University University of Southern California

Meyyazhagan Arun

Bharathiar University

Ingrid E.H. Kremer

Maastricht University

POSTER SESSION V: WEDNESDAY, 11 NOVEMBER 2015, 8:45 - 13:45 RESEARCH ON METHODS

PRM107

PRM113

PRM116

PRM123

PRM13

PRM134 PRM140 PRM142 PRM149 PRM151 PRM152

PRM164

PRM199

PRM2

PRM209 PRM216

SIMULATING INDIVIDUAL PATIENT LEVEL DATA USING AN ILLNESS-DEATH MODELLING FRAMEWORK IN ORDER TO ADJUST FOR TREATMENT SWITCHING WHEN ONLY SUMMARY DATA ARE AVAILABLE TIMED AUTOMATA MODELING OF THE PERSONALIZED TREATMENT DECISIONS IN METASTATIC CASTRATION RESISTANT PROSTATE CANCER REVIEWING THE COST-EFFECTIVENESS OF CHEMOTHERAPY AND TARGETED THERAPY FOR METASTATIC BREAST CANCER HOW TO MODEL SURVIVAL IN COST-EFFECTIVENESS ANALYSIS? DIFFERENCES BETWEEN MARKOV AND PARTITIONED SURVIVAL ANALYSIS MODELS NETWORK META-ANALYSIS OF MULTIPLE OUTCOMES INCORPORATING DOSE-RELATED CONSTRAINTS: APPLICATION TO OVERACTIVE BLADDER SYNDROME A SYSTEMATIC REVIEW AND TAXONOMY OF ECONOMIC EVALUATIONS OF PHARMACEUTICALS LICENSED ON THE BASIS OF UNCONTROLLED CLINICAL STUDIES MAPPING THE BECK DEPRESSION INVENTORY TO THE EQ5D-3L IN PATIENTS WITH DEPRESSIVE DISORDERS INTERNAL STRUCTURE OF THE MINNESOTA LIVING WITH HEART FAILURE QUESTIONNAIRE QUALITY OF LIFE INSTRUMENTS USED TO MEASURE JOBRELATED STRESS: A SYSTEMATIC REVIEW QUALITY OF LIFE ISSUES IMPORTANT TO PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES VALUATION OF THE EQ-5D-5L WITH COMPOSITE TIME TRADE-OFF FOR THE GERMAN POPULATION BARRIERS TO USING COMPUTER-ASSISTED TECHNOLOGY (CAT) IN CANCER PATIENT- REPORTED OUTCOME SURVEYS (PROS) OF TREATMENT TOXICITIES MEASUREMENT INVARIANCE OF THE WHOQOL-OLD MODULE ACROSS DIFFERENT DEMOGRAPHIC GROUPS IN TAIWAN'S ELDERLY PEOPLE HOW TO CONDUCT ECONOMIC EVALUATIONS OF NEW TREATMENTS FOR ADVANCED CANCER WHEN OVERALL SURVIVAL DATA ARE NOT AVAILABLE? RESULTS FROM A SYSTEMATIC LITERATURE REVIEW THE USE OF INDIRECT COMPARISONS IN MEDICINES EVALUATION FOR THEIR ACCESS TO REIMBURSEMENT BY THE HAS USING MACHINE LEARNING TECHNIQUES TO CLASSIFY OECD COUNTRIES ACCORDING TO HEALTH EXPENDITURES

PRM219 INDIRECT COMPARISONS IN BENEFIT ASSESSMENT A MIXED METHODS STUDY OF RESEARCHERS' PRM238 EXPERIENCES OF DEVELOPING CORE OUTCOME SETS

Rebecca Boucher

University of Leicester

Koen Degeling

University of Twente

Xavier G.L.V. Pouwels

Maastricht University Medical Center+

Rafael Minacori

Université Paris-Dauphine

Rhiannon Kate Owen

University of Leicester

Anthony J Hatswell Thomas Grochtdreis Amaia Bilbao

BresMed University Medical Center Hamburg-Eppendorf Basurto University Hospital (Osakidetza) - REDISSEC

Ah-ram Han

Ewha Womans University

Sam Salek Kristina Klose

University of Hertfordshire School of Public Health, Bielefeld University

Zahra Merali

Princess Margaret Cancer Centre

Po-Yu Hsieh

National Taiwan University

Catherine Beauchemin

University of Montreal

Marine Guichard Songul Cinaroglu Sarah Kühnast Elizabeth Gargon

Haute Autorité de Santé Hacettepe University Technical University of Dortmund University of Liverpool

APPLYING SYMPTOM-BASED UTILITY FUNCTIONS IN HEALTH ECONOMIC MODELLING: A CASE STUDY OF PRM258 UTERINE FIBROIDS HTA STUDIES FOR MEDICAL DEVICES INCORPORATING PRM281 THEIR MORAL AGEING COMPARISON OF COMORBIDITY MEASURES TO PREDICT ECONOMIC OUTCOMES IN A LARGE UK PRIMARY CARE PRM49 DATABASE VALIDATION OF A MARKOV MODEL FOR ECONOMIC EVALUATION OF SCREENING AND PREVENTIVE PRM73 INTERVENTIONS IN ALZHEIMER'S DISEASE IN DENMARK IMPACT OF UNCERTAINTY IN PREDICTED RISKS ON THE COST-EFFECTIVENESS OF RISK-STRATIFIED PREVENTIVE PRM82 TREATMENT STRATEGIES SELECTING EVIDENCE-BASED PREVENTIVE TREATMENT PRM93 THRESHOLDS BY OPTIMIZING PREFERRED OUTCOMES ECONOMIC AND CLINICAL IMPACT OF SECONDHAND PRM97 SMOKING IN KOREA

Kirk Geale Vojtech Kamensky

Antoine Bessou

Umeå University Czech Technical University in Prague National School For Statistics and Information Analysis (ENSAI)

Elizaveta Sopina

University of Southern Denmark

A van Giessen

University Medical Center Utrecht University Medical Center Utrecht

Jiyae Lee

Ewha Womans University

A van Giessen